Egyptian Drug Authority · Egypt
DEA-EG-2026-0031
Tier 1 · Regulator-publishedClass IIRecallStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(31) For 2026
- Date issued
- Apr 2026
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Staturic 40 mg
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 251120 · 251119 · 251118 · 251117 · 251116
- Expiry dates
- Not published with the notice
- Action type
- Recall
- Classification
- Class II as issued
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- Staturic 40 mg
251116و251117و251118و251119و251120
و251121و251122و251123و251124و251125و
251126
7/2028
P&C Labs for bio Med for pharmaceutical
industries (BIOMED)
وذلـــك بناءً على طلب شركة بايو ميد بع مل
سحب طوعي للتشغيلات الموضحة بعاليه من
المســـتحضر
وقف تداول و ضبط وتحريزالتشغيلات من
المستحضر الغير مطابقة للمواصفات
في حالة الشك في المستحضر الصيدلىيتم
الرجوع إلى هيئة الدواء المصرية سواء بالإتصال
بالخط الساخن 15301او الموقع الإلكترونى
الخاص بالهيئة.
أبريل 2026
اسم المستحضر
الشركة صاحبة
المستحضر
سبب التحذير
الإجراءات
التصحيحية
نصائح
للمستهلكين
منشور
سحب
هذا التنبية خاص بالتشغيلات الواردة في المنشور فقط ولا ينطبق على
تداول المستحضر بشكل عام
تاريخ الانتهاء
رقم التشغيلةOriginal language: ar
- Notice text in English
- Voluntary recall. Staturic 40 mg, batches 251116 to 251126 inclusive, expiry 7/2028, of P&C Labs for Bio Med for Pharmaceutical Industries (BIOMED). Issued at the request of Bio Med, which is carrying out a voluntary recall of the stated batches.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 3
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 20a88cc69de02b531fc8ea596408b4cda7465a22388845a2345f1cbde17b6c91SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:49:26 UTC
Cite this record
Drug Eye Africa (2026). DEA-EG-2026-0031: Staturic 40 mg — Recall, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2026/dea-eg-2026-0031Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.